148 related articles for article (PubMed ID: 35071411)
1. Significance of ovarian transposition in the preservation of ovarian function for young cervical cancer patients undergoing postoperative volumetric modulated radiotherapy.
Xu H; Guo C; Zhang X; Wu Y; Zhu B; Lu E; Sun Z; He D; Deng F; Lv J; Gong Z
Ann Transl Med; 2021 Dec; 9(23):1717. PubMed ID: 35071411
[TBL] [Abstract][Full Text] [Related]
2. Association between the location of transposed ovary and ovarian dose in patients with cervical cancer treated with postoperative pelvic radiotherapy.
Lv XJ; Cheng XL; Tu YQ; Yan DD; Tang Q
Radiat Oncol; 2019 Dec; 14(1):230. PubMed ID: 31842971
[TBL] [Abstract][Full Text] [Related]
3. Volumetric-modulated arc therapy for the treatment of a large planning target volume in thoracic esophageal cancer.
Abbas AS; Moseley D; Kassam Z; Kim SM; Cho C
J Appl Clin Med Phys; 2013 May; 14(3):4269. PubMed ID: 23652258
[TBL] [Abstract][Full Text] [Related]
4. Strategies for reducing ovarian dose in volumetric modulated arc therapy (VMAT) for postoperative uterine cervical cancer.
Yoshihiro U; Shingo O; Masaru I; Masayoshi M; Koji K; Shoji K; Iori S; Kazuhiko O; Teruki T
Br J Radiol; 2018 Jan; 91(1081):20160777. PubMed ID: 29072492
[TBL] [Abstract][Full Text] [Related]
5. Volumetric-modulated arc therapy vs. c-IMRT in esophageal cancer: a treatment planning comparison.
Yin L; Wu H; Gong J; Geng JH; Jiang F; Shi AH; Yu R; Li YH; Han SK; Xu B; Zhu GY
World J Gastroenterol; 2012 Oct; 18(37):5266-75. PubMed ID: 23066322
[TBL] [Abstract][Full Text] [Related]
6. Treatment Plan Technique and Quality for Single-Isocenter Stereotactic Ablative Radiotherapy of Multiple Lung Lesions with Volumetric-Modulated Arc Therapy or Intensity-Modulated Radiosurgery.
Quan K; Xu KM; Lalonde R; Horne ZD; Bernard ME; McCoy C; Clump DA; Burton SA; Heron DE
Front Oncol; 2015; 5():213. PubMed ID: 26500888
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated radiotherapy, coplanar volumetric-modulated arc, therapy, and noncoplanar volumetric-modulated arc therapy in, glioblastoma: A dosimetric comparison.
Hou Y; Zhang Y; Liu Z; Yv L; Liu K; Tian X; Lv Y
Clin Neurol Neurosurg; 2019 Dec; 187():105573. PubMed ID: 31706107
[TBL] [Abstract][Full Text] [Related]
8. A prospective trial of volumetric intensity-modulated arc therapy vs conventional intensity modulated radiation therapy in advanced head and neck cancer.
Fung-Kee-Fung SD; Hackett R; Hales L; Warren G; Singh AK
World J Clin Oncol; 2012 Apr; 3(4):57-62. PubMed ID: 22553505
[TBL] [Abstract][Full Text] [Related]
9. The relationship between ovarian function and ovarian limited dose in radiotherapy postoperation of ovarian transposition in young patients with cervical cancer.
Du Z; Qu H
Cancer Med; 2017 Mar; 6(3):508-515. PubMed ID: 28211638
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of a mixed beam therapy for postmastectomy breast cancer patients: Bolus electron conformal therapy combined with intensity modulated photon radiotherapy and volumetric modulated photon arc therapy.
Zhang R; Heins D; Sanders M; Guo B; Hogstrom K
Med Phys; 2018 Jul; 45(7):2912-2924. PubMed ID: 29749075
[TBL] [Abstract][Full Text] [Related]
11. Ovarian transposition before radiotherapy in cervical cancer patients: functional outcome and the adequate dose constraint.
Yin L; Lu S; Zhu J; Zhang W; Ke G
Radiat Oncol; 2019 Jun; 14(1):100. PubMed ID: 31182114
[TBL] [Abstract][Full Text] [Related]
12. A comparative dosimetric study of cervical cancer patients with para-aortic lymph node metastasis treated with volumetric modulated arc therapy
Wu Y; Zhu B; Han J; Xu H; Gong Z; Yang Y; Huang J; Lu E
Ann Transl Med; 2019 Nov; 7(22):675. PubMed ID: 31930076
[TBL] [Abstract][Full Text] [Related]
13. A comparative dosimetric study of volumetric-modulated arc therapy vs. fixed field intensity-modulated radiotherapy in postoperative irradiation of stage IB-IIA high-risk cervical cancer.
Qiao L; Cheng J; Liang N; Xie J; Luo H; Zhang J
Oncol Lett; 2016 Feb; 11(2):959-964. PubMed ID: 26893675
[TBL] [Abstract][Full Text] [Related]
14. Dosimetric study of a hybrid plan technique for external beam radiotherapy in patients with cervical cancer.
Martín-Tovar EA; Badillo-Alvarado AH; Cocom-Poot LE
Radiat Environ Biophys; 2021 Nov; 60(4):653-662. PubMed ID: 34363120
[TBL] [Abstract][Full Text] [Related]
15. Multi-Planar VMAT Plans for High-Grade Glioma and Glioblastoma Targeting the Hypothalamic-Pituitary Axis Sparing.
Cheung EYW; Ng SSH; Yung SHY; Cheng DYT; Chan FYC; Cheng JKY
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207484
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric Comparison of Whole Breast Radiotherapy Using Field-in-Field and Volumetric Modulated Arc Therapy Techniques in Left-Sided Breast Cancer Patients.
Waheed A; Butt S; Ishtiaq A; Mansha MA; Mehreen S; Raza M; Yousaf M
Cureus; 2021 Jun; 13(6):e15732. PubMed ID: 34285843
[TBL] [Abstract][Full Text] [Related]
17. [Dosimetric comparison of the helical tomotherapy, intensity-modulated radiotherapy and volumetric-modulated arc therapy in radical radiotherapy for esophageal cancer].
Xu YJ; Li P; Hu X; Wang J; Ma HL; Chen M
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3260-3265. PubMed ID: 31694123
[No Abstract] [Full Text] [Related]
18. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
[TBL] [Abstract][Full Text] [Related]
19. Volumetric-modulated arc therapy (VMAT) for whole brain radiotherapy: not only for hippocampal sparing, but also for reduction of dose to organs at risk.
Sood S; Pokhrel D; McClinton C; Lominska C; Badkul R; Jiang H; Wang F
Med Dosim; 2017 Winter; 42(4):375-383. PubMed ID: 28822604
[TBL] [Abstract][Full Text] [Related]
20. Is volumetric modulated arc therapy with constant dose rate a valid option in radiation therapy for head and neck cancer patients?
Didona A; Lancellotta V; Zucchetti C; Panizza BM; Frattegiani A; Iacco M; Di Pilato AC; Saldi S; Aristei C
Rep Pract Oncol Radiother; 2018; 23(3):175-182. PubMed ID: 29765265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
